RIZE — Rize Oncology Cashflow Statement
0.000.00%
Last trade - 00:00- CA$2.27m
- CA$0.68m
- 25
- 30
- 19
- 13
Annual cashflow statement for Rize Oncology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.073 | -1.64 | -1.72 | -0.688 | -0.551 |
| Non-Cash Items | 0 | 0.685 | 0.812 | 0.171 | 0.024 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.004 | 0.212 | -0.274 | 0.052 | 0.061 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Cash from Operating Activities | -0.069 | -0.74 | -1.18 | -0.465 | -0.466 |
| Financing Cash Flow Items | — | — | — | — | 0.347 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.104 | 0.875 | 3 | — | 0.347 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.035 | 0.134 | 1.62 | -0.432 | -0.202 |